FindTrial
Sign In

A study on quality of life in Prosthakola veekkam (Benign prostatic hyperplasia) patients taking siddha treatment

Assessment of quality of life in patients taking siddha treatment for prosthakola veekkam (Benign prostatic hyperplasia) reporting at Ayothidoss Pandithar Hospital,National Institute of Siddha-An observational study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/02/049626
Enrollment
20
Registered
2023-02-10
Start date
Unknown
Completion date
Unknown
Last updated
2023-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N401- Benign prostatic hyperplasia withlower urinary tract symptoms

Interventions

None listed

Sponsors

National Institute of Siddha
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.K/C/O Benign Prostatic Hyperplasia and newly diagnosed BPH patients 2.Patients who would take 48 days of Siddha treatment for Prosthakola veekkam (BPH) at Ayothidoss Pandithar hospital NIS 3.Patients who are willing to give informed consent

Exclusion criteria

Exclusion criteria: 1. Age below 50 and above 80 years 2.K/C/O Prostatic malignancy 3.K/C/O Urinary bladder calculus 4.Patients with prior history of prostatic/urethral surgery

Design outcomes

Primary

MeasureTime frame
Difference in BPH Specific Quality of life scale will be assessed form baseline through endpoint with Benign Prostatic hyperplasia targeted siddha treatmentTimepoint: 4 months-Data collection 2 months- Data analysis and outcome—

Secondary

MeasureTime frame
NILTimepoint: NIL—

Countries

India

Contacts

Public ContactDr J Franchiska Vinnarasi

National Institute of Siddha

drlakshmiramaswamy@gmail.com9025575185

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026